Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial
Author(s) -
Dan Turner,
Jason Bishai,
Leah Reshef,
Guila Abitbol,
Gili Focht,
Dana Marcus,
Oren Ledder,
Raffi LevTzion,
E Orlanski-Meyer,
Baruch Yerushalmi,
Marina Aloi,
Anne M. Griffiths,
Lindsey Albenberg,
KaijaLeena Kolho,
Amit Assa,
Shlomi Cohen,
Uri Gophna,
Hera Vlamakis,
Eberhard Lurz,
Arie Levine
Publication year - 2019
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izz298
Subject(s) - medicine , metronidazole , microbiome , randomized controlled trial , antibiotics , ulcerative colitis , amoxicillin , colitis , gastroenterology , disease , bioinformatics , microbiology and biotechnology , biology
Alterations in the microbiome have been postulated to drive inflammation in IBD. In this pilot randomized controlled trial, we evaluated the effectiveness of quadruple antibiotic cocktail in addition to intravenous-corticosteroids (IVCSs) in acute severe colitis (ASC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom